Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)
NCT ID: NCT04119544
Last Updated: 2025-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
66 participants
INTERVENTIONAL
2019-12-10
2028-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The use of mirror therapy allows the activation of the mirror neurons involved to stimulate brain plasticity after brain damage.The IVS (Intensive Visual Stimulation) device allows an easy implementation of mirror therapy by filming the valid upper limb and projecting the inverted image onto a screen placed above the parietal arm thus producing the illusion of movement of the parietal arm.
The main hypothesis of this study is that the structured practice of a large number of upper limb targeted movement repetitions using an intensive visual numerical simulation device as a partial replacement for routine care (conventional occupational therapy) in the sub-acute phase of stroke will increase the active function (motor function and functional abilities) of the distal end of the upper limb compared to conventional rehabilitation.
Objectives: This randomized controlled trial will evaluate the effects of partial substitution of routine care (occupational therapy) by structured movement repetition programs by Intensive Visual Simulation using an IVS3 device, on the distal motor control of the upper hemiparesis limb, between 4 and 10 weeks after the stroke, compared to a program with conventional care alone.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Study to Evaluate the Observance Rehabilitation of Upper Limbs by Visual-motor Simulation Associated at Transcranial Direct Current Stimulation (tDCS) in Hemiparetic Patient Post-stroke
NCT03815266
Integration and Interactions Between Visual and Proprioceptive Feedbacks
NCT06931509
Mirror vs Virtual Reality Therapy for Upper Extremity Function in Hemiplegic Patients
NCT07018336
Mirror Therapy Efficacy in Upper Limb Rehabilitation Early After Stroke
NCT03418883
Use of Tendon Vibration and Mirror for the Improvement of Upper Limb Function and Pain Reduction
NCT01010607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis: The structured practice of repeating upper limb movements by Intensive Visual Simulation will increase distal motor control, and improve the objective functional abilities of the upper limb.
Main Objective:Evaluate in a controlled protocol the effects, on the distal motor control of the upper hemiparesis limb, between 4 and 10 weeks after stroke, of 6 weeks of partial substitution of routine care (occupational therapy) by structured movement repetition programs by Intensive Visual Simulation using an IVS3 device, compared to 6 weeks of a program involving only conventional rehabilitation care, in a population of moderate to severe hemiparesis stroke patients in subacute phase.
Device Description: The IVS3 (Intensive Visual Simulation) rehabilitation device, marketed by Dessintey, allows the implementation of intensive mirror therapy by making it more immersive, ergonomic, and accessible. The IVS3 device consists of a hollow table adjustable in height, a touch screen dedicated to the therapist to set up the device and a large screen adjustable in height and sliding laterally to overlap the upper limb and thus allow the illusion that the limb visible on the screen is the paretic upper limb.
Methods: Multicentric randomised controlled Trial.
Risk/Constraint: To our knowledge, this research does not involve any risks other than those of daily life. The medical device will be used under normal conditions of use as described in the user manual. No contraindications are specified for this device. A risk of discomfort may be felt by the patient during the first few minutes of use. Possibility of feeling tired.
Research duration : 8 years Duration of patient participation : 18 weeks
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional Rehabilitation
at least 4 sessions/week for 6 weeks, from 1 hour of conventional upper limb rehabilitation by an occupational therapist.
Conventional rehabilitation
upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
Intensive Visual Simulation
at least 4 sessions/week for 6 weeks, of 1 hour of upper limb rehabilitation including 45 minutes of conventional rehabilitation (occupational therapy) and 15 minutes of work with a medical device allowing intensive visual digital simulation.
Conventional rehabilitation
upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
Intensive Visual Simulation
* First week: observation, mentalization and then attempt to perform the movements on the screen.
* Second and third weeks: production of analytical movements of wrist flexion/extension, pronation/supination, finger flexion/extension, thumb opposition.
* From the 4th week until the end: depending on the patient's motor capacities, continuation of the work of the previous 2 weeks or introduction of more functional work with object manipulation, gripping work.
Conventional rehabilitation upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conventional rehabilitation
upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
Intensive Visual Simulation
* First week: observation, mentalization and then attempt to perform the movements on the screen.
* Second and third weeks: production of analytical movements of wrist flexion/extension, pronation/supination, finger flexion/extension, thumb opposition.
* From the 4th week until the end: depending on the patient's motor capacities, continuation of the work of the previous 2 weeks or introduction of more functional work with object manipulation, gripping work.
Conventional rehabilitation upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stroke hemiparesis on unilateral focal lesion dating from 4 to 10 weeks at baseline;
* Total sub-scores wrist and hand of th Fugl-Meyer \< 16
* Patient having agreed to sign an informed consent
* patient being affiliated to the French Social Security
Exclusion Criteria
* Phasic disorders that prevent the understanding of instructions
* Patient include in an other clinical trial
* Neurological conditions prior to stroke
* Patient who had mirror therapy or IVS rehabilitation before inclusion
* Rheumatological pathology of the hand and wrist
* Person under legal protection measure.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinalliance Villiers-sur-Orge
UNKNOWN
Centre de Rééducation Fonctionnelle Pasori
UNKNOWN
CHU de Reims
OTHER
Clinique Les Grands Chênes
UNKNOWN
Clinique Napoléon
UNKNOWN
Clinique Mariénia
UNKNOWN
Clinique Verdaich
UNKNOWN
Clinique Les Trois Soleils
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christophe DURET, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique Les Trois Soleils
Manuel Wiese, MD
Role: PRINCIPAL_INVESTIGATOR
Clinalliance Villiers-sur-Orge
Nikolay DOBREV, MD
Role: PRINCIPAL_INVESTIGATOR
CRF PASORI
François BOYER, Professor
Role: PRINCIPAL_INVESTIGATOR
Hôpital Sébastopol, CHU de Reims
Caroline TERRACOL, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique Marienia Inicea
Jean-Marc GUEBLE, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique Verdaich
Adrien PETIT, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique Les Grands Chênes Inicea
Magali CAPLANNE, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique Napoléon Inicea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Sébastopol
Reims, Champagne-Ardenne, France
Clinique Napoléon
Saint-Paul-lès-Dax, Nouvelle-Aquitaine, France
Clinique Les Trois Soleils
Boissise-le-Roi, , France
CRF Pasori
Cosne-Cours-sur-Loire, , France
Clinalliance Villiers-sur Orge
Villiers-sur-Orge, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A00966-51
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.